KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Operating Margin (2016 - 2025)

Abbott Laboratories' Operating Margin history spans 17 years, with the latest figure at 19.64% for Q4 2025.

  • For Q4 2025, Operating Margin rose 223.0% year-over-year to 19.64%; the TTM value through Dec 2025 reached 18.17%, up 190.0%, while the annual FY2025 figure was 18.17%, 190.0% up from the prior year.
  • Operating Margin for Q4 2025 was 19.64% at Abbott Laboratories, up from 18.09% in the prior quarter.
  • Across five years, Operating Margin topped out at 24.48% in Q1 2022 and bottomed at 12.92% in Q4 2022.
  • The 5-year median for Operating Margin is 17.4% (2023), against an average of 17.76%.
  • The largest annual shift saw Operating Margin skyrocketed 1036bps in 2021 before it plummeted -900bps in 2023.
  • A 5-year view of Operating Margin shows it stood at 20.74% in 2021, then tumbled by -38bps to 12.92% in 2022, then surged by 35bps to 17.38% in 2023, then grew by 0bps to 17.41% in 2024, then increased by 13bps to 19.64% in 2025.
  • Per Business Quant, the three most recent readings for ABT's Operating Margin are 19.64% (Q4 2025), 18.09% (Q3 2025), and 18.42% (Q2 2025).